CompletedNot Applicable

Smartphone App-assisted PPI

Switzerland60 participantsStarted 2023-09-05

Plain-language summary

Proton pump inhibitors (PPIs) are frequently prescribed for 30 days but taken infinitely. PPIs belong to the most often inappropriate medicines (PIMs). Correct intake of medicines (named adherence) can be supported by digital devices such as smartphone applications. The goal of this interventional study is to test the feasibility of an app-based treatment support provided by community pharmacists in patients prescribed a short-term PPI (30 days). The intervention consists in tracking medication intake, symptom course and well-being over the treatment duration of 30 days with the mednet app on patients' personal smartphones.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * is ≥18 years old; * has symptoms that suggest or correspond to gastroesophageal reflux disease (GERD); * is newly prescribed a short-term PPI treatment; * accepts to use of the smartphone app mednet during the study period; * signs the informed consent form; * understands and speaks (Swiss) German. Exclusion Criteria: * in the opinion of the pharmacist or physician, unlikely to comply with the study schedule or are unsuitable for any other reason.

What they're measuring

Patients with PPI treatment over 30 days

Timeframe: 30 days (treatment duration)

Trial details

NCT IDNCT06094062

SponsorUniversity Hospital, Basel, Switzerland

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-15

View on ClinicalTrials.gov More Heartburn trials